HomeDGX • NYSE
add
Quest Diagnostics Inc
Previous close
$162.47
Day range
$161.69 - $166.00
Year range
$123.18 - $167.08
Market cap
18.24B USD
Avg Volume
932.64K
P/E ratio
21.32
Dividend yield
1.96%
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.62B | 14.55% |
Operating expense | 497.00M | 11.94% |
Net income | 222.00M | 15.62% |
Net profit margin | 8.47 | 0.95% |
Earnings per share | 2.23 | 3.72% |
EBITDA | 496.00M | 22.47% |
Effective tax rate | 22.37% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 549.00M | -19.97% |
Total assets | 16.15B | 15.20% |
Total liabilities | 9.26B | 21.74% |
Total equity | 6.90B | — |
Shares outstanding | 111.00M | — |
Price to book | 2.66 | — |
Return on assets | 5.60% | — |
Return on capital | 6.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 222.00M | 15.62% |
Cash from operations | 464.00M | -11.95% |
Cash from investing | -502.00M | -340.35% |
Cash from financing | -170.00M | -230.77% |
Net change in cash | -215.00M | -139.59% |
Free cash flow | 294.00M | 8.39% |
About
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
Founded
1967
Website
Employees
55,000
